Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AngioDynamics Inc ANGO

Healthcare Medical Devices
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the... see more

Recent & Breaking News (NDAQ:ANGO)

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

PR Newswire January 9, 2017

AngioDynamics Reports Fiscal 2017 Second Quarter Results

GlobeNewswire January 6, 2017

AngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 3, 2017

AngioDynamics to Report Fiscal 2017 Second Quarter Financial Results

GlobeNewswire December 20, 2016

AngioDynamics to Participate in Upcoming Investor Conferences

GlobeNewswire November 28, 2016

15 Biggest Mid-Day Losers For Tuesday

Benzinga.com  November 15, 2016

20 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  November 15, 2016

AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders

GlobeNewswire November 14, 2016

AngioDynamics Announces Secondary Offering of 2,500,000 Shares of Common Stock by Selling Stockholders

GlobeNewswire November 14, 2016

AngioDynamics Announces New Senior Credit Facilities and New Share Repurchase Program

GlobeNewswire November 9, 2016

AngioDynamics Announces Addition of New Board Members: Eileen Auen, Former Executive Chairman of Helios and Jan Stern Reed, Former General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc.

GlobeNewswire November 9, 2016

AngioDynamics to Present at the 2016 Canaccord Genuity Medical Technologies and Diagnostics Forum

GlobeNewswire November 7, 2016

AngioDynamics Reports Fiscal 2017 First Quarter Results

GlobeNewswire October 5, 2016

AngioDynamics to Report Fiscal 2017 First Quarter Financial Results

GlobeNewswire September 21, 2016

AngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference

GlobeNewswire September 6, 2016

AngioDynamics to Present at the 2016 Canaccord Genuity Growth Conference

GlobeNewswire August 8, 2016

18 Biggest Mid-Day Losers For Tuesday

Benzinga.com  August 2, 2016

15 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  August 2, 2016

AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders

GlobeNewswire August 1, 2016

AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer

GlobeNewswire July 25, 2016